NASDAQ:OFIX
Orthofix Medical Inc.
Orthofix Medical Inc.'s revenue grew 2.9% in fiscal 2025 to $822.3M while operating margin rose to −9.9%. Free cash flow was −$1.3M, −0.2% of revenue, and the diluted share count rose 3.9%.Summary generated from Orthofix Medical Inc.'s SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$822.3M
Revenue growth+2.9%
Revenue, 5-yr CAGR+15.1%
Gross margin68.8%
Operating margin−9.9%
Net margin−11.2%
ROIC−11.7%
Return on equity−19.3%
Debt / equity0.35
Free cash flow−$1.3M
FCF margin−0.2%
Share count change+3.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 464 | 461 | 747 | 799 | 822 |
| Operating income | −8 | −13 | −139 | −85 | −81 |
| Net income | −38 | −20 | −151 | −126 | −92 |
| Free cash flow | 1 | −33 | −106 | −9 | −1 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Sep 22, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KRegulation FD disclosure
Jul 2, 2026 - 8-KDirector or officer change
Jun 11, 2026 - 8-KRegulation FD disclosure
May 21, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026